Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Aphria, Cronos Group, EXMceuticals - it is a buyers' market!

The shares of numerous well-known and unknown cannabis companies have had a dramatic year 2019. Price losses of over 50% are not uncommon. What costs only half today may have become twice as attractive. Due to the large number of cannabis companies listed on the stock exchange...
Mario Hose | January 21, 2020 |

Earning into 3 Exciting Opportunities. Who, What, Where, When & Why?

Looking for a value play in a well-structured mining exploration and development company? Well, Tocvan Ventures Corp. (TOC) ( CSE.TOC , OTCQB: TCVNF , Forum ) may be the kind of investment opportunity that is worth delving deeper into. TOC is currently e...
Dave Jackson | March 23, 2022 |

Ibogaine Drug Development: Creating The Gold Standard For Addiction Treatment

(Click image to play video.) A renewed interest in the therapeutic power psychedelic of compounds is revealing a potent and commercially viable solution. Vancouver BC-based Universal Ibogaine Inc. (UI) ( TSX-V: IBO , Forum ) is positioned to address the opioid e...
Dave Jackson | October 26, 2021 |

How a junior copper and gold explorer added the coveted Santa Cecilia project to its portfolio

The copper price has had a booming 2021 — having reached an all-time high of US$4.90 in May of this year — and companies in the space have been reaping the benefits of this year’s hottest metal. Meet Vancouver, BC-based Torq Resources Inc. ( TSXV:TORQ ,...
Jocelyn Aspa | November 12, 2021 |

Building Europe’s First Lithium Hydroxide Converter

(Click to watch video) Back in July , our Stockhouse audience first met up with Rock Tech Lithium Inc. ( TSXV:RCK , Forum ) – a cleantech company that’s aiming to serve the automotive industry with high-quality lithium by building Europe&Clos...
Dave Jackson | October 27, 2021 |

Buzz on the Bullboards: New Year, New Stocks?

The beginning of a new year always sparks hope and signals new possibilities — and that same logic can be applied to the stock market. 2021 certainly had its plethora of ups and downs, but the Canadian market finished off the year strong and the sentiment remains bul...
Stockhouse Editorial | January 5, 2022 |

Immuno-Oncology Firm Expands Agreement with AbbVie

The revisions to the existing arrangement between the two U.S. firms are discussed in a ROTH Capital Partners report. In a Nov. 21 research note, ROTH Capital Partners analyst Zegbeh Jallah reported that Harpoon Therapeutics Inc. (HARP:NASDAQ) and AbbVie Inc. (ABBV...
Streetwise Reports | December 5, 2019 |

Biopharma 'Keeps Executing and Securing Milestones'

The company's latest achievement and partnership potential are addressed in a ROTH Capital Partners report. In a Dec. 12 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Daré Bioscience Inc. (DARE:NASDAQ) received U.S. Food and Drug Adminis...
Streetwise Reports | December 19, 2019 |

Applied Genetic Tech's Shares Double on 6-Month X-Linked RP Study Results

Shares of Applied Genetic Technologies skyrocketed to a new 52-week high price after the company reported positive six-month data from its ongoing Phase 1/2 clinical study for treatment in X-Linked Retinitis Pigmentosa. The firm stated that the trial data suggests durable and ...
Streetwise Reports | January 10, 2020 |

Oil & Gas Midstream MLP Offers 'Multiyear Financial Performance/Flexibility'

A recap of Q4/19 and the outlook for 2020-2021 are provided in a Raymond James report. In a Jan. 31 research note, Raymond James analyst Justin Jenkins reported that for Phillips 66 Partners LP (PSXP:NYSE) , "upside in Q4/19 set the pace for 2020 visibility...
Streetwise Reports | February 7, 2020 |
1 2 3 4 5 6 7 8 9 10 ...